# Publications Reference Table

This table provides a quick reference for all publications in the database, useful for content creation and analysis work.

## Quick Stats
- **Total Publications**: 27 (excluding removed preprint duplicate)
- **Featured Publications**: 4 (+ 1 featured new + 2 preprints to feature)
- **Projects**: PEARL (majority), JHEEM
- **Years**: 2018-2025
- **Preprints**: 2 (to be replaced when published)

---

## All Publications

| ID | Year | Featured | First Author | Title (Shortened) | Journal | Link | Project | PDF | Key Findings | Image |
|----|------|----------|--------------|-------------------|---------|------|---------|-----|--------------|-------|
| `forster-2025` | 2025 | ✅ | Forster R | Potential Impact of Ending Ryan White HIV/AIDS Program on HIV Incidence (31 US cities) | Ann Intern Med | [DOI](https://doi.org/10.7326/ANNALS-25-01737) | JHEEM | ✅ | ✅ (drafted) | ❌ |
| `zalesak-2025` | 2025 | ❌ (preprint) | Zalesak A | Proposed Cuts to Ryan White Parts C/D Could Raise HIV Incidence 18% (30 states + DC) | medRxiv (preprint) | [DOI](https://doi.org/10.1101/2025.10.14.25337745) | JHEEM | ✅ | ✅ (drafted) | ❌ |
| `balasubramanian-2025` | 2025 | ❌ (preprint) | Balasubramanian R | Potential Effect of Ending CDC Funding for HIV Tests (18 states) | medRxiv (preprint) | [DOI](https://doi.org/10.1101/2025.09.19.25336182) | JHEEM | ✅ | ✅ (drafted) | ❌ |
| `althoff-2024` | 2024 | ✅ | Althoff KN | Forecasted prevalence of comorbidities and multimorbidity in PWH (2030) | PLoS Medicine | [DOI](https://doi.org/10.1371/journal.pmed.1004325) | PEARL | ✅ | ❌ | Placeholder |
| `schnuremc-2024` | 2024 | ❌ | Schnure MC | Forecasting effect of HIV interventions on age distribution in Kenya | AIDS | [DOI](https://doi.org/10.1097/QAD.0000000000003895) | JHEEM | ❌ | ❌ | ❌ |
| `hyle-2023` | 2023 | ✅ | Hyle EP | Growing number of MSM aging with HIV (2021-2031) - model comparison | J Infect Dis | [DOI](https://doi.org/10.1093/infdis/jiac473) | PEARL | ✅ | ❌ | ❌ |
| `kasaie-2023-subgroup` | 2023 | ❌ | Kasaie P | Impact of subgroup heterogeneities on forecasted population size and deaths | Ann Epidemiol | [DOI](https://doi.org/10.1016/j.annepidem.2023.09.005) | PEARL | ❌ | ❌ | ❌ |
| `nosykb-2023` | 2023 | ❌ | Nosyk B | Testing imperative for US EHE program | Clin Infect Dis | [DOI](https://doi.org/10.1093/cid/ciad103) | JHEEM | ❌ | ❌ | ❌ |
| `hyle-2022` | 2022 | ❌ | Hyle EP | MSM aging with HIV (2021-2031) - microsimulation models | J Infect Dis | [DOI](https://doi.org/10.1093/infdis/jiac473) | PEARL | ❌ | ❌ | ❌ |
| `althoff-2022-med` | 2022 | ❌ | Althoff KN | Projected prevalence of comorbidities/multimorbidity through 2030 (preprint) | medRxiv | [DOI](https://doi.org/10.11010/2022.11.04.22281891) | PEARL | ❌ | ❌ | ❌ |
| `fojo-2022-covid-hiv` | 2022 | ❌ | Fojo A | Potential effects of COVID-19 on HIV transmission (32 US cities) | Clin Infect Dis | [DOI](https://doi.org/10.1093/cid/ciab1029) | JHEEM | ❌ | ❌ | ❌ |
| `balasubramanianr-2022` | 2022 | ❌ | Balasubramanian R | Projected impact of expanded long-acting injectable PrEP among MSM | JAIDS | [DOI](https://doi.org/10.1097/QAI.0000000000003029) | JHEEM | ❌ | ❌ | ❌ |
| `edwardsjk-2022` | 2022 | ❌ | Edwards JK | 5-year mortality for adults entering HIV care under universal early treatment | Clin Infect Dis | [DOI](https://doi.org/10.1093/cid/ciab1030) | PEARL | ❌ | ❌ | ❌ |
| `althoff-2021` | 2021 | ✅ | Althoff KN | Shifting age distribution of PWH using ART in US (2020-2030) | AIDS | [DOI](https://doi.org/10.1097/QAD.0000000000003128) | PEARL | ✅ | ❌ | Placeholder |
| `kasaie-2021` | 2021 | ❌ | Kasaie P | Projecting age distribution of MSM receiving HIV treatment in US | Ann Epidemiol | [DOI](https://doi.org/10.1016/j.annepidem.2021.08.021) | PEARL | ❌ | ❌ | ❌ |
| `fojo-2021-end-hiv` | 2021 | ✅ | Fojo AT | What will it take to end HIV in the US? (32 MSAs) | Ann Intern Med | [DOI](https://doi.org/10.7326/M21-1501) | JHEEM | ✅ | ❌ | ❌ |
| `kasaiep-2020` | 2020 | ❌ | Kasaie P | Integrated screening/treatment for HIV, hypertension, diabetes in Kenya | JIAS | [DOI](https://doi.org/10.1002/jia2.25499) | JHEEM | ❌ | ❌ | ❌ |
| `pretoriusc-2020` | 2020 | ❌ | Pretorius C | Impact/cost-effectiveness of oral PrEP in 13 low-resource countries | JIAS | [DOI](https://doi.org/10.1002/jia2.25451) | JHEEM | ❌ | ❌ | ❌ |
| `kasaie-2018-spain-art` | 2018 | ❌ | Kasaie P | Economic/epidemiologic impact of early ART guidelines in Spain | Clin Infect Dis | [URL](https://pubmed.ncbi.nlm.nih.gov/PMID) | JHEEM | ❌ | ❌ | ❌ |

---

## Featured Publications Detail

### 1. Althoff 2024 - Comorbidities & Multimorbidity Forecast
- **Status**: Analysis complete, key figure identified, findings drafted
- **Key Figure**: Figure 2 (pages 12-13)
- **PDF**: `docs/publications/althoff-2024.pdf`
- **DOI**: 10.1371/journal.pmed.1004325
- **Access**: Open access (PLoS)

### 2. Hyle 2023 - MSM Aging with HIV
- **Status**: Analysis complete, key figure identified, findings drafted
- **Key Figure**: Figure 2 (pages 4-5)
- **PDF**: `docs/publications/hyle-2023.pdf`
- **DOI**: 10.1093/infdis/jiac473
- **Access**: Journal subscription may be required

### 3. Althoff 2021 - Shifting Age Distribution
- **Status**: Analysis complete, key figure identified, findings drafted
- **Key Figure**: Figure 3a (page 15)
- **PDF**: `docs/publications/althoff-2021.pdf`
- **DOI**: 10.1097/QAD.0000000000003128
- **Access**: Author manuscript (PMC 2023)

### 4. Fojo 2021 - Ending HIV Epidemic
- **Status**: Analysis complete, key figure identified, findings drafted
- **Key Figure**: Figure 4 (page 19)
- **PDF**: `docs/publications/fojo-2021-end-hiv.pdf`
- **DOI**: 10.7326/M21-1501
- **Access**: Open access (PMC)

---

## Publications by Project

### PEARL Project (13 publications)
Focus: Projecting Age, multimoRbidity, and poLypharmacy in adults with HIV

- Althoff 2024 ⭐
- Hyle 2023 ⭐
- Kasaie 2023 (subgroup heterogeneities)
- Hyle 2022
- Althoff 2022 (preprint)
- Edwards 2022
- Althoff 2021 ⭐
- Kasaie 2021

### JHEEM Project (16 publications)
Focus: Johns Hopkins HIV Economic-Epidemiologic Model

- **Forster 2025** ⭐ (Ryan White - full program impact, 31 cities)
- **Zalesak 2025** (preprint) (Ryan White Parts C/D/MAI/EHE, 30 states + DC)
- **Balasubramanian 2025** (preprint) (CDC testing impact, 18 states)
- Schnure 2024
- Nosyk 2023
- Fojo 2022 (COVID-19)
- Balasubramanian 2022 (long-acting PrEP)
- Fojo 2021 ⭐
- Kasaie 2020 (Kenya)
- Pretorius 2020
- Kasaie 2018 (Spain)

---

## Analysis Workflow Checklist

For each publication requiring content extraction:

- [ ] Locate PDF file
- [ ] Read abstract and conclusions
- [ ] Identify key figure (most impactful visualization)
- [ ] Draft 1-2 sentence key findings
- [ ] Note copyright/access status
- [ ] Get author verification (if team member)
- [ ] Extract figure file
- [ ] Add to `publications.ts`

---

## Notes

- All featured publications have team members as authors (can get verification)
- PDFs stored in `docs/publications/` (gitignored from Vercel builds)
- See `featured-pubs-analysis.md` for detailed analysis of featured publications
- Priority: Complete featured publications first, then expand to others as needed

### Recent Changes

- **Removed:** `althoff-2022-med` (medRxiv preprint) - duplicate of published `althoff-2024` (PLoS Medicine)
- **New (Published):** `forster-2025` added - Ryan White full program impact (31 cities), published September 2025 in Ann Intern Med - **FEATURED**
- **New (Preprints):** Two related preprints added:
  - `zalesak-2025` - Ryan White Parts C/D/MAI/EHE cuts (30 states + DC), posted October 2025
  - `balasubramanian-2025` - CDC testing funding cuts (18 states), posted September 2025

### The 2025 Policy Research Trilogy

Three complementary studies examine different aspects of HIV program disruptions:
1. **Forster 2025** (Published): Full Ryan White cessation → 75K excess infections (49% ↑)
2. **Zalesak 2025** (Preprint): Partial Ryan White cuts → 24K excess infections (18% ↑)
3. **Balasubramanian 2025** (Preprint): CDC testing cuts → 13K excess infections (10% ↑)

All use JHEEM model, all demonstrate disproportionate rural/underserved impact, all have interactive web tools.
